trial summary · NCT07668817
Tract Closure in PCNL
Defining the Role of Hemostatic Agents in Percutaneous Nephrolithotomy: A Randomized Controlled Trial of Tract Closure Techniques
Trial record from the TrialBase DB dataset, status RECRUITING, condition Nephrolithiasis, sponsored by Icahn School of Medicine at Mount Sinai. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This is a prospective, randomized controlled trial evaluating the effect of a hemostatic agent on tract-related bleeding during percutaneous nephrolithotomy (PCNL). Patients undergoing standardized PCNL will be randomized to receive either application of a hemostatic agent or no agent during tract closure, following uniform balloon occlusion, complete aspiration, and irrigation-free endoscopic assessment. The researchers hypothesize that adjunctive hemostatic agent use reduces perioperative hemoglobin decline compared with balloon tamponade alone and improves tract-related hemostasis outcomes.
Source record: https://clinicaltrials.gov/study/NCT07668817
Facts
| registry id | NCT07668817 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Nephrolithiasis |
| sponsor | Icahn School of Medicine at Mount Sinai |
| sponsor class | OTHER |
| enrollment | 92 |
| start date | 2026-10-26 |
| primary completion | 2028-05 |
| completion | 2028-06 |
| results posted | not reported |
Conditions
- Nephrolithiasis
Interventions
- Floseal
- Surgicel
- Surgiflo
- Balloon Tamponade
Countries
- United States
Intervention types: DEVICE, PROCEDURE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.